Phase II trial of nab- sirolimus in patients with advanced malignant perivascular epithelioid cell tumors (AMPECT): Long-term efficacy and safety update Journal Article
| Authors: | Wagner, A. J.; Ravi, V.; Riedel, R. F.; Ganjoo, K.; Van Tine, B. A.; Chugh, R.; Cranmer, L.; Gordon, E. M.; Hornick, J. L.; Du, H.; Ding, L.; Schmid, A. N.; Navarro, W. H.; Kwiatkowski, D. J.; Dickson, M. A. |
| Article Title: | Phase II trial of nab- sirolimus in patients with advanced malignant perivascular epithelioid cell tumors (AMPECT): Long-term efficacy and safety update |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 13 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-05-01 |
| Start Page: | 1472 |
| End Page: | 1476 |
| Language: | English |
| DOI: | 10.1200/jco.23.02266 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl plus with full text |
| PUBMED: | 38427923 |
| PMCID: | PMC11095855 |
| DOI/URL: | |
| Notes: | MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PubMed -- Source: CINAHL Plus with Full Text |
